These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 7780640)
1. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Cox SL; Ben A; Story DF; Ziogas J Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat. Cox SL; Story DF; Ziogas J Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747 [TBL] [Abstract][Full Text] [Related]
3. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat. Cox SL; Story DF; Ziogas J Br J Pharmacol; 1996 Nov; 119(5):976-84. PubMed ID: 8922748 [TBL] [Abstract][Full Text] [Related]
4. Characterization of contractile response to angiotensin in epididymal rat vas deferens. Sum CS; Cheung WT Pharmacology; 1995 Aug; 51(2):105-11. PubMed ID: 8584570 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens. Sum CS; Wan DC; Cheung WT Br J Pharmacol; 1996 Jul; 118(6):1523-9. PubMed ID: 8832081 [TBL] [Abstract][Full Text] [Related]
7. An electrophysiological study of the actions of angiotensin II at the sympathetic neuroeffector junction in the guinea-pig vas deferens. Ziogas J; Cunnane TC Br J Pharmacol; 1991 May; 103(1):1196-202. PubMed ID: 1878757 [TBL] [Abstract][Full Text] [Related]
8. Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit. Hegde SS; Clarke DE J Pharmacol Exp Ther; 1993 May; 265(2):601-8. PubMed ID: 8496811 [TBL] [Abstract][Full Text] [Related]
9. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497 [TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. Shetty SS; DelGrande D J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats. Wong PC; Christ DD; Timmermans PB Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998 [TBL] [Abstract][Full Text] [Related]
12. Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats. Ruiz-Gayo M; Somoza B; Bravo R; Fernández-Alfonso MS; González C Life Sci; 2000 Nov; 67(26):3153-62. PubMed ID: 11191622 [TBL] [Abstract][Full Text] [Related]
13. Novel angiotensin receptor subtypes in fowl. Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II AT1 receptor mediated contraction of the perfused rat cerebral artery. Näveri L; Strömberg C; Saavedra JM Neuroreport; 1994 Nov; 5(17):2278-80. PubMed ID: 7881045 [TBL] [Abstract][Full Text] [Related]
15. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670 [TBL] [Abstract][Full Text] [Related]
16. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries. Li Q; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024 [TBL] [Abstract][Full Text] [Related]
17. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations. Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955 [TBL] [Abstract][Full Text] [Related]
18. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related]
19. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity. Catalioto RM; Renzetti AR; Criscuoli M; Mizrahi J; Subissi A Eur J Pharmacol; 1994 Apr; 256(1):93-7. PubMed ID: 8026565 [TBL] [Abstract][Full Text] [Related]
20. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery. Onaka U; Fujii K; Abe I; Fujishima M Br J Pharmacol; 1997 Nov; 122(5):942-8. PubMed ID: 9384513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]